Potassium Phosphates
Potassium Phosphates is an IV phosphorus supplement used to restore low phosphate levels or support nutrition when eating or tube feeding isn't possible.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 1 clinical label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
How we combine label and product data →
Patient information guide — a plain-language walkthrough of Potassium Phosphates, written from its FDA label.
What Potassium Phosphates is used for
▾
Potassium Phosphates injection is used to supply phosphorus through the vein when the body can't get enough another way. The main uses include:
- Correcting hypophosphatemia (dangerously low blood phosphate levels) in adults and children when oral or tube-fed phosphorus isn't possible or isn't working
- Parenteral nutrition support — added to complete IV nutrition for adults and children who cannot eat or be tube-fed
How Potassium Phosphates works
▾
Phosphorus is a mineral your body depends on for almost everything at the cellular level. It forms the backbone of DNA, powers the energy molecule your cells run on, helps regulate your body's acid-base balance, supports bone strength, and keeps cell membranes intact. When phosphate levels fall too low, these essential processes break down. This injection delivers phosphate directly into the bloodstream, bypassing the gut entirely, so your body can restore normal function quickly.
Potassium Phosphates dosage
▾
This medication is given only in a hospital or clinical setting — always through an IV, and always after being diluted into a larger bag of IV fluid. It is never given undiluted or as a fast push into a vein. The infusion is given slowly, with the rate and amount tailored to your lab values, weight, age, and overall condition.
- Administered through a peripheral vein (arm) or a central line depending on the concentration required
- Your blood levels of phosphorus, potassium, calcium, and magnesium are monitored throughout
- Dosing is fully individualized — follow your care team's instructions
Dosing details from the FDA-approved label
From the Potassium Phosphates prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
Use this potassium phosphates in sodium chloride injection product only in patients who require the entire 15 mmoL phosphorus dose (potassium 22 mEq) and not any fraction thereof.
Read the label’s full dosing text
2 DOSAGE AND ADMINISTRATION Important Preparation Instructions • Do NOT dilute prior to administration. ( 2.1 ) • Use this potassium phosphates in sodium chloride injection product only in patients who require the entire 15 mmoL phosphorus dose (potassium 22 mEq) and not any fraction thereof. If the entire 15 mmol phosphorus dose is not required, consider an alternative formulation of potassium phosphate. ( 2.1 ) Important Administration Instructions • Potassium Phosphates in Sodium Chloride Injection is only for administration to a patient with a serum potassium concentration less than 4 mEq/dL; otherwise, use an alternative source of phosphorus. ( 2.2 ) • This product contains phosphorus 15 mmol and potassium 22 mEq. ( 2.2 ) o The 100 mL ready-to-use container is for intravenous infusion into a central vein. o The 250 mL ready-to-use container is for intravenous infusion into a central or peripheral vein. Recommended Dosage • See full prescribing information for recommendations on initial or single dosing, repeated dosing, concentration and infusion rate. ( 2.3 ) • Monitor serum phosphorus, potassium, calcium, and magnesium concentrations. ( 2.3 ) • Patients with moderate renal impairment should start at the low end of the dosage range. Potassium Phosphates in Sodium Chloride Injection is contraindicated in patients with severe renal impairment. ( 2.4 , 4 ) 2.1 Important Preparation Instructions • Potassium Phosphates in Sodium Chloride Injection is for intravenous infusion into a central or peripheral vein. Do NOT dilute prior to administration. • Use this potassium phosphates in sodium chloride injection product only in patients who require the entire 15 mmoL phosphorus dose (potassium 22 mEq) and not any fraction thereof. • If a dose of potassium phosphate is required that does not equal 15 mmoL of Potassium phosphates in Sodium Chloride Injection, then an alternative formulation of potassium phosphates should be considered. • Visually inspect the solution for particulate matter and discoloration prior to administration. Do not administer unless solution is clear, and the seal of the container is intact. • Always inspect the solution container before and after removal from the overwrap. • Place the solution container on a clean, flat surface. Remove the solution container from the overwrap. • Check the solution container for leaks by squeezing firmly.
Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →
Potassium Phosphates side effects
▾
Common side effects
- High potassium levels (hyperkalemia)
- High phosphate levels (hyperphosphatemia)
- Low calcium levels (hypocalcemia)
- Low magnesium levels (hypomagnesemia)
- Diarrhea or stomach pain
- Weakness
- Confusion or lethargy
- Decreased urine output
When to get medical help
- Call for emergency help immediately if you notice a racing, irregular, or very slow heartbeat, or chest pain — these can be signs of a dangerous heart rhythm.
- Tell your care team right away if you feel sudden weakness, paralysis, or numbness/tingling — these can be signs of dangerously high potassium.
- Report any sudden trouble breathing or shortness of breath during or after the infusion.
- Let your team know if you notice swelling, very little urine output, or signs of kidney problems.
- Patients with kidney disease, adrenal problems, or who take medications that raise potassium are at higher risk and need especially close monitoring.
Because this drug affects key electrolytes, the side effects to watch for are mostly changes in your blood chemistry and heart function. Reported side effects include:
- High potassium (hyperkalemia) — can cause heart rhythm problems and muscle weakness
- High phosphate (hyperphosphatemia) — can lower calcium levels
- Low calcium (hypocalcemia) — tingling, muscle cramps, or spasms
- Low magnesium (hypomagnesemia)
- Low blood pressure, heart rhythm changes, or chest pain
- Shortness of breath
- Diarrhea or stomach pain
- Confusion, lethargy, weakness, or numbness
- Decreased urine output or kidney injury
Serious reactions like cardiac arrest, heart block, or severe electrolyte shifts require immediate medical attention — your care team will be monitoring for these during the infusion.
Potassium Phosphates warnings and precautions
▾
- Never give undiluted or too fast: Rapid or undiluted infusions have caused death, cardiac arrest, dangerous heart rhythms (including QT prolongation), seizures, and very high potassium. This is the most critical safety rule with this drug.
- High potassium (hyperkalemia): Risk is greatest in people with kidney disease, adrenal problems, or those on drugs that raise potassium. Heart patients are especially vulnerable. ECG monitoring may be needed.
- High phosphate and low calcium: Too much phosphate can drop calcium levels severely, and can cause calcium deposits in soft tissues and organs — including the kidneys.
- Aluminum toxicity: The product contains trace aluminum; patients with kidney problems (including premature infants) face higher risk of aluminum buildup over time.
- Low magnesium: Has been reported, especially in patients with high calcium or diabetic ketoacidosis. Magnesium is monitored during treatment.
- Vein damage and clots: Concentrated or high-osmolarity solutions must go through a central line to avoid damaging smaller veins.
Potassium Phosphates interactions
▾
Because potassium phosphates raise potassium levels in the blood, combining it with other potassium-raising drugs is especially dangerous. Key interactions include:
- Potassium-sparing diuretics (e.g., spironolactone) — reduce the kidney's ability to remove potassium, compounding the risk of hyperkalemia
- ACE inhibitors (e.g., lisinopril, enalapril) — commonly used for blood pressure or heart failure; can push potassium higher when combined
- Angiotensin II receptor blockers (ARBs) (e.g., losartan, valsartan) — similar concern to ACE inhibitors
- Digoxin — a heart medication whose effects are altered by potassium imbalances
- Tacrolimus and cyclosporine — immunosuppressants used in transplant patients; both raise potassium independently
Interactions listed in the FDA-approved label
From the Potassium Phosphates prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
Use of Other Medications that Increase Potassium : Avoid use in patients receiving such products. If use cannot be avoided, closely monitor serum potassium concentrations.
Read the label’s full interactions text
7 DRUG INTERACTIONS Use of Other Medications that Increase Potassium : Avoid use in patients receiving such products. If use cannot be avoided, closely monitor serum potassium concentrations. ( 5.2 , 7.1 ) 7.1 Other Products that Increase Serum Potassium Administration of Potassium Phosphates in Sodium Chloride Injection to patients treated concurrently or recently with products that increase serum potassium (e.g., potassium-sparing diuretics, ACE inhibitors, angiotensin II receptor antagonists, digoxin, or the immunosuppressants tacrolimus and cyclosporine) increases the risk of severe and potentially fatal hyperkalemia, especially in the presence of other risk factors for hyperkalemia [see Warnings and Precautions ( 5.2 )] . Avoid use of Potassium Phosphates in Sodium Chloride Injection in patients receiving such products. If use cannot be avoided, closely monitor serum potassium concentrations [see Dosage and Administration ( 2.3 )] .
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Potassium Phosphates
▾
- Already have high potassium (hyperkalemia): This drug cannot be used — it adds more potassium.
- Already have high phosphate (hyperphosphatemia): Contraindicated — you don't need more phosphate.
- High calcium or significantly low calcium: Both are contraindications; mineral balance must be right before starting.
- Severe kidney disease or dialysis: The kidneys can't clear the extra phosphate and potassium safely — this drug is contraindicated in these patients.
- Moderate kidney disease: Still a risk factor for hyperkalemia and aluminum buildup — close monitoring is needed.
- Pregnancy: Phosphorus is essential and IV replacement may be appropriate when oral options aren't possible — discuss with your doctor.
- Breastfeeding: Not expected to harm a nursing infant at recommended doses, but discuss with your care team.
- Children under 40 kg (about 88 lbs): This specific ready-to-use product is not approved for smaller children — a different formulation is required.
- Cardiac disease: Extra caution is needed because the heart is more sensitive to potassium swings.
Potassium Phosphates overdose
▾
Too much potassium phosphate — especially given as a large single dose or too quickly — can cause death, cardiac arrest, dangerous heart rhythms, seizures, very high potassium, very high phosphate, and a dangerous drop in calcium. Very high potassium specifically can cause slow or chaotic heartbeats, low blood pressure, severe muscle weakness, and paralysis. If an overdose is suspected, the infusion should be stopped immediately and emergency supportive care started, including heart monitoring and correction of electrolyte levels.
What Potassium Phosphates does in the body
▾
The full exposure-response relationship for potassium phosphates — meaning exactly how much drug is needed to produce a given effect — has not been completely worked out. What is known is that phosphorus plays essential roles across nearly every organ system, and restoring it corrects the disruptions caused by low phosphate levels. Monitoring blood phosphorus, potassium, calcium, and magnesium levels is the main way clinicians track whether the treatment is working and staying safe.
How your body processes Potassium Phosphates
▾
Once in the bloodstream, about 85% of phosphate circulates freely in the blood, while about 15% is bound to proteins. Phosphate that isn't taken up by the body's tissues is filtered by the kidneys — more than 80% of what the kidneys filter is actively reabsorbed back into the body, and the rest is excreted in the urine. This means kidney function has a major influence on how well the body handles phosphate, which is why kidney disease significantly raises the risk of phosphate and potassium buildup.
How to store Potassium Phosphates
▾
Store at 20°C to 25°C (68°F to 77°F) .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Potassium Phosphates: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Potassium Phosphates — the kind of thing our pharmacy team would talk through with you at the counter.
Why am I getting this through an IV instead of just taking a phosphorus pill?
▾
Is it safe to get this if I have kidney problems?
▾
What side effects should I actually watch out for during the infusion?
▾
I take a blood pressure medicine — does that matter?
▾
I'm pregnant — is this safe for my baby?
▾
How will my doctors know the infusion is working and that I'm staying safe?
▾
Is Potassium Phosphates available over the counter?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Potassium Phosphates on HelloPharmacist
How widely Potassium Phosphates is used (Medicaid data)
A general measure of how commonly Potassium Phosphates is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Potassium Phosphates is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Potassium Phosphates prescribed? Of the 1,599 medications we measure, Potassium Phosphates ranks #1,136 by Medicaid prescriptions — more than 29% of them.
Utilization by Potassium Phosphates product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
monobasic potassium phosphate 0.0408 MEQ/ML Oral Solution
Summed across the 2 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1101775
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Potassium Phosphates, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 2 of 2 listed Potassium Phosphates NDCs with Medicaid activity.
Potassium Phosphates side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Potassium Phosphates — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Potassium Phosphates in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Potassium Phosphates FDA approval history
How Potassium Phosphates went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Potassium Phosphates recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Potassium Phosphates recalls since July 2021.
✅No Potassium Phosphates recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 34322 1 dose form · 1 strength
-
Dose form (SCDF) Oral Solution RxCUI 434905No current FDA listingClinical drug / strength (SCD) monobasic potassium phosphate 0.0408 MEQ/MLRxCUI 1101775
Look up RxCUI 34322 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Potassium Phosphates supply and shortage status
Whether Potassium Phosphates is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
Potassium Phosphates brand names
Potassium Phosphates is sold under one brand name in the FDA directory — K-Phos. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Sources for this Potassium Phosphates page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Fresenius Kabi USA, LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →